What Oruka Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 55 | 122 |
| Total trades | 75 | 178 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 326,458 | 4,353,602 |
| Disposed | 232,895 | 4,050,142 |
| Net activity | +93,563 | +303,460 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Quinlan Paul T | General Counsel | Oct 20 | Open-market sale · S | −3,000 | $79.49 | −$238K | 29,995 |
| Quinlan Paul T | General Counsel | Oct 20 | Open-market sale · S | −4,100 | $78.79 | −$323K | 32,995 |
| Quinlan Paul T | General Counsel | Oct 20 | Open-market sale · S | −1,000 | $77.21 | −$77.2K | 37,095 |
| Quinlan Paul T | General Counsel | Oct 20 | Open-market sale · S | −500 | $76.12 | −$38.1K | 38,095 |
| Quinlan Paul T | General Counsel | Oct 20 | Open-market sale · S | −400 | $74.90 | −$30K | 38,595 |
| Quinlan Paul T | General Counsel | Oct 20 | Exercise / conversion · M | +9,000 | $7.80 | +$70.2K | 38,995 |
| Goncalves Joana | Chief Medical Officer | Oct 15 | Open-market sale · S | −200 | $77.71 | −$15.5K | 31,771 |
| Goncalves Joana | Chief Medical Officer | Oct 15 | Open-market sale · S | −700 | $76.67 | −$53.7K | 31,971 |
| Goncalves Joana | Chief Medical Officer | Oct 15 | Open-market sale · S | −1,400 | $75.48 | −$106K | 32,671 |
| Goncalves Joana | Chief Medical Officer | Oct 15 | Open-market sale · S | −1,847 | $74.69 | −$138K | 34,071 |
| Goncalves Joana | Chief Medical Officer | Oct 15 | Open-market sale · S | −2,853 | $73.89 | −$211K | 35,918 |
| Goncalves Joana | Chief Medical Officer | Oct 15 | Exercise / conversion · M | +3,500 | $7.80 | +$27.3K | 38,771 |
| Goncalves Joana | Chief Medical Officer | Oct 15 | Exercise / conversion · M | +3,500 | $6.84 | +$23.9K | 35,271 |
| Agarwal Arjun | Senior Vice President, Finance | Oct 12 | Open-market sale · S | −200 | $82.84 | −$16.6K | 14,219 |
| Agarwal Arjun | Senior Vice President, Finance | Oct 12 | Open-market sale · S | −1,958 | $81.86 | −$160K | 14,419 |
| Agarwal Arjun | Senior Vice President, Finance | Oct 12 | Open-market sale · S | −2,100 | $80.76 | −$170K | 16,377 |
| Agarwal Arjun | Senior Vice President, Finance | Oct 12 | Open-market sale · S | −5,741 | $80.03 | −$459K | 18,477 |
| Agarwal Arjun | Senior Vice President, Finance | Oct 12 | Exercise / conversion · M | +1,458 | $34.39 | +$50.1K | 24,218 |
| Agarwal Arjun | Senior Vice President, Finance | Oct 12 | Exercise / conversion · M | +8,541 | $12.50 | +$107K | 22,760 |
| Klein Lawrence Otto | Chief Executive Officer | Oct 01 | Open-market sale · S | −200 | $84.78 | −$17K | 923,128 |
Loading...
